Table 5. Comparison between subjects who attended the survivor clinic versus subjects who did not attend the clinic (in subjects with at least 5-year post-treatment follow-up).
| SURVIVOR CLINIC ATTENDANCE (N=47) |
NO SURVIVOR ATTENDANCE CLINIC (N=148) |
||||
|---|---|---|---|---|---|
| Median | Range | Median | Range | p-value | |
| Age at Diagnosis (yrs) | 4.5 | 0.5-19.0 | 9.0 | 0-20.0 | 0.0124 |
| N | % | N | % | p-value | |
| Irregular Periods at last follow-up | 4 | 9 | 10 | 25 | 0.7733 |
| Menarche before Diagnosis | 9 | 19 | 46 | 43 | 0.033 |
| Amenorrhea >12 months post treatment | 4 | 9 | 10 | 20 | 0.7275 |
| FSH level >10 (more than 10) | 4 | 9 | 13 | 9 | 0.9999 |
| Radiation Therapy | 13 | 28 | 35 | 24 | 0.611 |
| Chemotherapy | 46 | 98 | 104 | 72 | <0.001 |
| Bone Marrow Transplant | 5 | 11 | 10 | 7 | 0.3622 |
| Alkylating Agent | 31 | 66 | 60 | 42 | 0.004 |
| Anthracycline Agent | 39 | 83 | 61 | 42 | <0.001 |